Nuvisan Icb GmbH

Nuvisan Icb GmbH is a company in Berlin, Germany that has taken part in 6 EU-funded projects since 2020, receiving €2.7M in EU funding.

EU funding received€2.7M
EU projects6
As coordinator0
Running now5
First EU project2020
Latest project2026
CountryGermany
EU registration (PIC)895404382
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Nuvisan Icb GmbH's own share of each project, not the project's full budget.

  • Horizon 2020€1.7M · 1 project
  • Horizon Europe€975k · 5 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • hope4PMOSPartner

    Harnessing biobanking, Organ models, and Patient Empowerment for a better quality of life for women living within Polyendocrine Metabolic Ovary Syndrome

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €975ktheir share
  • LIGAND-AIPartner

    Protein-ligand data generation at scale to support computational hit finding and optimization

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • CATALOOPAssociated partner

    Closing the loop in stereoselective catalysis with data-driven approaches

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • PANVIPREPAssociated partner

    Developing broad-spectrum antiviral drugs for pandemic preparedness

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

  • IN-ARMORPartner

    THERAPEUTIC EPIGENETIC ENHANCEMENT OF THE INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANCE [IN-ARMOR]

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • CAREPartner

    Corona Accelerated R&D in Europe

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €1.7Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA viruses
  • antivirals
  • bacteriology
  • catalysis
  • coronaviruses
  • drug discovery
  • machine learning
  • medicinal chemistry
  • mortality
  • mycology
  • pandemics
  • pharmacokinetics
  • proteins
  • public health

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime